Dipeptidyl Peptidase-4 Inhibitors and Risk of Inflammatory Bowel Disease among Patients with Type 2 Diabetes Mellitus

First published 24/10/2018

Last updated 02/07/2024

EU PAS number:

EUPAS26245

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

DPP4i_IBD protocol_ENCePP_22Oct18

English (449.34 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents